Invenomic Capital Management’s nLIGHT LASR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-165,269
Closed -$3.25M 163
2025
Q2
$3.25M Sell
165,269
-705,121
-81% -$8.76M 0.18% 118
2025
Q1
$6.76M Buy
+870,390
New +$8.76M 0.34% 93
2024
Q3
Sell
-57,481
Closed -$628K 166
2024
Q2
$628K Sell
57,481
-31,869
-36% -$388K 0.03% 157
2024
Q1
$1.16M Buy
89,350
+4,973
+6% +$65.2K 0.06% 137
2023
Q4
$1.14M Buy
+84,377
New +$944K 0.05% 157
2023
Q2
Sell
-419,828
Closed -$4.27M 147
2023
Q1
$4.27M Sell
419,828
-293,190
-41% -$3.38M 0.24% 100
2022
Q4
$7.23M Buy
713,018
+143,398
+25% +$1.48M 0.49% 72
2022
Q3
$5.38M Buy
569,620
+121,527
+27% +$1.4M 0.46% 71
2022
Q2
$4.58M Buy
448,093
+349,006
+352% +$4.51M 0.32% 85
2022
Q1
$1.26M Buy
+99,087
New +$1.86M 0.13% 123

Other funds holding LASR

Invenomic Capital Management's LASR Position: Q3 2025 in Review

Invenomic Capital Management sold out of nLIGHT (LASR) in Q3 2025, closing a stake of 165,269 shares — an estimated $3.25M sold.

Invenomic Capital Management first reported a position in LASR in Q1 2022 and held it in 10 quarters. The position peaked at $7.23M in Q4 2022. 225 funds tracked by Wall St. Rank hold LASR as of Q3 2025.

  • Invenomic Capital Management reported no remaining nLIGHT position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 165,269 nLIGHT shares in Q3 2025, an estimated $3.25M.
  • Invenomic Capital Management first reported a position in nLIGHT in Q1 2022 and held it in 10 quarters.
  • Invenomic Capital Management's nLIGHT position peaked at $7.23M in Q4 2022.
  • 225 funds tracked by Wall St. Rank held nLIGHT as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.